Ligand Pharmaceuticals (NASDAQ:LGND) Shares Up 7 3% Following Strong Earnings wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Ligand Pharmaceuticals (NASDAQ:LGND – Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Tuesday, May 7th. Analysts expect Ligand Pharmaceuticals to post earnings of $1.13 per share for the quarter. Ligand Pharmaceuticals has set its FY 2024 guidance at 4.250-4.750 EPS and its FY24 guidance at $4.25 […]
Ligand Pharmaceuticals (NASDAQ:LGND) Releases Earnings Results, Beats Expectations By $0 66 EPS etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Ligand Pharmaceuticals (NASDAQ:LGND – Get Free Report) had its price objective dropped by equities researchers at Barclays from $120.00 to $110.00 in a report issued on Tuesday, MarketBeat.com reports. The brokerage currently has an “overweight” rating on the biotechnology company’s stock. Barclays‘s price target would indicate a potential upside of 63.96% from the stock’s previous […]
StockNews.com upgraded shares of Ligand Pharmaceuticals (NASDAQ:LGND – Get Rating) from a hold rating to a buy rating in a research note published on Saturday. Several other equities research analysts also recently commented on LGND. HC Wainwright lifted their price objective on shares of Ligand Pharmaceuticals from $135.00 to $144.00 in a research note on […]